Dr. Michael Hayden awarded Aubrey J. Tingle Prize
We are pleased to announce that Dr. Michael Hayden is the recipient of the second annual Aubrey J. Tingle Prize.
Created in honour of the founding President & CEO of the Michael Smith Foundation for Health Research, this award is given to a British Columbia clinician scientist or scholar practitioner whose work in health research is internationally recognized and has significant impact on advancing clinical or health services and policy research.
“It is very fitting that Dr. Hayden receive this award,” says Dr. John Challis, MSFHR President & CEO. “His many contributions to the field of genetic research have positioned BC as a global leader and we look forward to following his future work.”
As one of the world’s most accomplished researchers in neurodegenerative diseases, Dr. Hayden’s contributions to medical genetics are highly acclaimed and celebrated. He has made numerous discoveries, including the role that genes play in coronary artery disease and adverse drug reactions, as well as the development of a predictive genetic test for Huntington’s disease, where he also recently provided the first evidence of a potential cure.
Dr. Hayden has been praised as a motivated scientist who is always eager to push the boundaries of science and to challenge those around him. He has also recently been honoured with the 2011 Killam Prize, the inaugural Margolese National Brain Disorder Prize, the Genome BC Award for Scientific Excellence, and the Canada Gairdner Wightman Award for his outstanding national and international leadership for medical genetics, entrepreneurship and humanitarianism.
Dr. Hayden is Director and Senior Scientist at the Centre for Molecular Medicine and Therapeutics at the Child & Family Research Institute, University Killam Professor in the Department of Medical Genetics at the University of British Columbia, and member of the Michael Smith Foundation for Health Research Board of Directors.
Dr. Hayden will receive $10,000 and present at an MSFHR event later this year.